VIP280

N/A

Report date: 2023/05/31 15:47:36
NME

Base Information

Drug NameVIP280
Drug Alias NameVIP-280VIP280
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsPositive transcriptional elongation factor B inhibitors
TargetsCyclin-dependent kinase 9Positive transcriptional elongation factor B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVincerx Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesVincerx Pharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A